Favorable Q3 Financial Reports Lift Largest Psychedelic Sector Stocks By 22%

Chart, Trading, Courses, Forex, Analysis

Image Source: Pixabay

After a pretty sharp slide from the end of July to mid-October, the 5 constituents in the munKNEE Psychedelic Drug Stocks Index are bouncing - up 22% on average last week. Here's how they rank, in descending order, according to their performances last week, along with any pertinent news affecting that performance.

  1. Mind Medicine (MNMD): up 25.0% last week
  2. Atai Life Sciences (ATAI): up 24.5% last week
  3. GH Research (GHRS): up 22.9% last week
  4. Compass Pathways (CMPS): up 21.2% last week
  5. Incannex Healthcare (IXHL): up 10.0% last week
    • is researching and developing therapies and products with the world's largest portfolio of medicinal cannabinoid and psychedelic pharmaceutical products.

Summary

The munKNEE Psychedelic Drug Stocks Index was up 22.0% last week (down 6.5% the previous week) and is now down 18.1% YTD.


More By This Author:

Cannabis Investors Have Thrown In The Towel: American MSOs Down 21% This Week
AI Bubble Pricked: Top 11 Stocks Down 7.6% MTD; Still +165% YTD
Quantum Computing Hardware Developers Index Down 7% MTD; Now Only +1% YTD

Disclosure: None

Visit  munKNEE.com and register to receive our free Market Intelligence Report newsletter (sample  more

How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.
Or Sign in with